Cargando…

Controlled Ovarian Stimulation with recombinant-FSH plus recombinant-LH vs. human Menopausal Gonadotropin based on the number of retrieved oocytes: results from a routine clinical practice in a real-life population

BACKGROUND: The association of recombinant FSH (rFSH) plus recombinant LH (rLH) is currently used for Controlled Ovarian Stimulation (COS) in human IVF, but its efficacy has, to date, not yet been compared to that of human Menopausal Gonadotropin (hMG), the FSH + LH activity-containing urinary drug....

Descripción completa

Detalles Bibliográficos
Autores principales:	Revelli, Alberto, Pettinau, Grazia, Basso, Gemma, Carosso, Andrea, Ferrero, Alessandro, Dallan, Cecilia, Canosa, Stefano, Gennarelli, Gianluca, Guidetti, Daniela, Filippini, Claudia, Benedetto, Chiara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514947/ https://www.ncbi.nlm.nih.gov/pubmed/26209525 http://dx.doi.org/10.1186/s12958-015-0080-6

Ejemplares similares

Probabilistic cost-effectiveness analysis of controlled ovarian stimulation with recombinant FSH plus recombinant LH vs. human menopausal gonadotropin for women undergoing IVF
por: Mennini, F. S., et al.
Publicado: (2018)

Effect of rLH Supplementation during Controlled Ovarian Stimulation for IVF: Evidence from a Retrospective Analysis of 1470 Poor/Suboptimal/Normal Responders Receiving Either rFSH plus rLH or rFSH Alone
por: Canosa, Stefano, et al.
Publicado: (2022)

Human Recombinant FSH and Its Biosimilars: Clinical Efficacy, Safety, and Cost-Effectiveness in Controlled Ovarian Stimulation for In Vitro Fertilization
por: Bergandi, Loredana, et al.
Publicado: (2020)

Does Ovarian Endometriosis Increase Oocyte Sensitivity to ICSI-Induced Mechanical Damage?
por: Scarafia, Carlotta, et al.
Publicado: (2021)

Luteal Support with very Low Daily Dose of Human Chorionic Gonadotropin after Fresh Embryo Transfer as an Alternative to Cycle Segmentation for High Responders Patients Undergoing Gonadotropin-Releasing Hormone Agonist-Triggered IVF
por: Carosso, Andrea Roberto, et al.
Publicado: (2021)

Comparison between cycles of the same patients when using recombinant luteinizing hormone + recombinant follicle stimulating hormone (rFSH), human menopausal gonadotropin + rFSH and rFSH only
por: Tayyar, Ahter Tanay, et al.
Publicado: (2018)

Human Menopausal Gonadotropin versus Recombinant FSH in Polycystic Ovary Syndrome Patients Undergoing In Vitro Fertilization
por: Figen Turkcapar, Ayse, et al.
Publicado: (2013)

Women in Advanced Reproductive Age: Are the Follicular Output Rate, the Follicle-Oocyte Index and the Ovarian Sensitivity Index Predictors of Live Birth in an IVF Cycle?
por: Carosso, Andrea Roberto, et al.
Publicado: (2022)

Establishment of specific enzyme-linked immunosorbent assay (ELISA) for measuring Fsh and Lh levels in medaka (Oryzias latipes), using recombinant gonadotropins
por: Burow, Susann, et al.
Publicado: (2019)

Effect of a Combination of Myo-Inositol, Alpha-Lipoic Acid, and Folic Acid on Oocyte Morphology and Embryo Morphokinetics in non-PCOS Overweight/Obese Patients Undergoing IVF: A Pilot, Prospective, Randomized Study
por: Canosa, Stefano, et al.
Publicado: (2020)

Recombinant versus highly-purified, urinary follicle-stimulating hormone (r-FSH vs. HP-uFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysis
por: Revelli, Alberto, et al.
Publicado: (2006)

Impact of the addition of Early Embryo Viability Assessment to morphological evaluation on the accuracy of embryo selection on day 3 or day 5: a retrospective analysis
por: Revelli, Alberto, et al.
Publicado: (2019)

ICSI versus Conventional IVF in Women Aged 40 Years or More and Unexplained Infertility: A Retrospective Evaluation of 685 Cycles with Propensity Score Model
por: Gennarelli, Gianluca, et al.
Publicado: (2019)

Differential gene expression in human granulosa cells from recombinant FSH versus human menopausal gonadotropin ovarian stimulation protocols
por: Brannian, John, et al.
Publicado: (2010)

Recombinant follicular stimulating hormone plus recombinant luteinizing hormone versus human menopausal gonadotropins- does the source of LH bioactivity affect ovarian stimulation outcome?
por: Kirshenbaum, M., et al.
Publicado: (2021)

Differential Regulation of Gonadotropins as Revealed by Transcriptomes of Distinct LH and FSH Cells of Fish Pituitary
por: Hollander-Cohen, Lian, et al.
Publicado: (2021)

Associations of LH and FSH with reproductive hormones depending on each stage of the menopausal transition
por: Kawakita, Takako, et al.
Publicado: (2023)

The Ovarian Sensitivity Index (OSI) Significantly Correlates with Ovarian Reserve Biomarkers, Is More Predictive of Clinical Pregnancy than the Total Number of Oocytes, and Is Consistent in Consecutive IVF Cycles
por: Revelli, Alberto, et al.
Publicado: (2020)

The optimal period for oocyte retrieval after the administration of recombinant human chorionic gonadotropin in in vitro fertilization
por: Al Rahwanji, Mhd Jawad, et al.
Publicado: (2022)

Reproductive and Obstetric Outcomes Following a Natural Cycle vs. Artificial Endometrial Preparation for Frozen–Thawed Embryo Transfer: A Retrospective Cohort Study
por: Carosso, Andrea Roberto, et al.
Publicado: (2023)

Comparison of recombinant human follicle stimulating hormone (rhFSH), human chorionic gonadotropin (HCG) and human menopausal gonadotropin (HMG) on semen parameters after varicocelectomy: a randomized clinical trial
por: Amirzargar, Mohammad Ali, et al.
Publicado: (2012)

Effects of recombinant LH supplementation to recombinant FSH during induced ovarian stimulation in the GnRH-agonist protocol: a matched case-control study
por: Franco, José G, et al.
Publicado: (2009)

Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Personalized” Medicine Era: A Meta-analysis
por: Santi, Daniele, et al.
Publicado: (2017)

What is the effect of the early follicular phase FSH/LH ratio on the number of mature oocytes and embryo development?
por: ARAT, Özgür, et al.
Publicado: (2020)

Body Mass Index and Gonadotropin Hormones (LH & FSH) Associate With Clinical Symptoms Among Women With Polycystic Ovary Syndrome
por: Esmaeilzadeh, Seddigheh, et al.
Publicado: (2015)

Recombinant Fsh and Lh therapy for spawning induction of previtellogenic and early spermatogenic arrested teleost, the flathead grey mullet (Mugil cephalus)
por: Ramos-Júdez, Sandra, et al.
Publicado: (2022)

Equine Chorionic Gonadotropin as an Effective FSH Replacement for In Vitro Ovine Follicle and Oocyte Development
por: Di Berardino, Chiara, et al.
Publicado: (2021)

Commentary: Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Personalized” Medicine Era: A Meta-analysis
por: Younis, Johnny S.
Publicado: (2017)

Correlation of the Day 3 FSH/LH Ratio and LH Concentration in Predicting IVF Outcome
por: Prasad, Sudha, et al.
Publicado: (2013)

Human recombinant follicle stimulating hormone (rFSH) compared to urinary human menopausal gonadotropin (HMG) for ovarian stimulation in assisted reproduction: a literature review and cost evaluation
por: Levi Setti, P. E., et al.
Publicado: (2014)

Response: Commentary: Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Personalized” Medicine Era: A Meta-analysis
por: Santi, Daniele, et al.
Publicado: (2018)

The Role of Urinary LH and FSH in the Diagnosis of Pubertal Disorders
por: Tripathy, Manoranjan, et al.
Publicado: (2021)

Effects of human chorionic gonadotropin combined with clomiphene on Serum E(2), FSH, LH and PRL levels in patients with polycystic ovarian syndrome
por: Yonggang, Huang, et al.
Publicado: (2017)

Oestrogen-selective modulation of FSH and LH secretion by pituitary gland
por: Mitwally, M F, et al.
Publicado: (2005)

Weak evidence of bright light effects on human LH and FSH
por: Kripke, Daniel F, et al.
Publicado: (2010)

Reduced FSH and LH action: implications for medically assisted reproduction
por: Bosch, E, et al.
Publicado: (2021)

Regulation of progesterone during follicular development by FSH and LH in sheep
por: Ding, Ziqiang, et al.
Publicado: (2022)

Expectant Management Before In vitro Fertilization in Women Aged 39 or Above and Unexplained Infertility Does Not Decrease Live Birth Rates Compared to Immediate Treatment
por: Carosso, Andrea Roberto, et al.
Publicado: (2021)

Effects of Extra-Long-Acting Recombinant Bovine FSH (bscrFSH) on Cattle Superovulation
por: Gutiérrez-Reinoso, Miguel A., et al.
Publicado: (2022)

Letter to Editor on “Correlation of the Day 3 FSH/LH Ratio and LH Concentration in Predicting IVF Outcome”
por: Morgante, Giuseppe
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_52vfgmkac5qd8orhhuqq512cti